Evolent Health Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Evolent Health ha aumentado sus beneficios a una tasa media anual de 35.7%, mientras que los beneficios de la industria de Healthcare Services han experimentado un crecimiento anual de 14%. Los ingresos han ido creciendo a una tasa media de 25.1% al año.
Información clave
35.7%
Tasa de crecimiento de los beneficios
42.6%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare Services | 1.7% |
Tasa de crecimiento de los ingresos | 25.1% |
Rentabilidad financiera | -5.9% |
Margen neto | -4.2% |
Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Evolent Health: A Shot At Revival After Market Bruising
Nov 12Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper
Nov 09We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)
Nov 07Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet
Sep 19Evolent Health: Let The Bidding Begin
Aug 23Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk
Jul 29Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Jul 01Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)
May 22These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well
May 05Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares
Apr 08Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital
Mar 12Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
Jan 17Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)
Dec 21Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
Nov 30A First Evaluation On Evolent Health
Oct 04Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?
Sep 29There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital
Sep 01An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued
Aug 04Evolent Health: Business Economics Still Appealing, Reiterate Buy
Jul 19Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely
Jun 14Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt
May 30An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued
May 02Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue
Apr 17Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M
Feb 22Is Evolent Health (NYSE:EVH) A Risky Investment?
Feb 19Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return
Feb 15Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?
Feb 01Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger
Jan 14Evolent spikes as Humana partnership expands
Jan 12Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?
Dec 27Evolent Health offered $23.5M class action securities settlement
Sep 19Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher
Sep 18Desglose de ingresos y gastos
Cómo gana y gasta dinero Evolent Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Sep 24 | 2,464 | -104 | 244 | 0 |
30 Jun 24 | 2,354 | -106 | 275 | 0 |
31 Mar 24 | 2,176 | -141 | 298 | 0 |
31 Dec 23 | 1,964 | -142 | 306 | 0 |
30 Sep 23 | 1,790 | -112 | 327 | 0 |
30 Jun 23 | 1,632 | -77 | 298 | 0 |
31 Mar 23 | 1,483 | -40 | 263 | 0 |
31 Dec 22 | 1,352 | -19 | 244 | 0 |
30 Sep 22 | 1,218 | -4 | 243 | 0 |
30 Jun 22 | 1,088 | -19 | 229 | 0 |
31 Mar 22 | 990 | -24 | 215 | 0 |
31 Dec 21 | 908 | -30 | 208 | 0 |
30 Sep 21 | 906 | -45 | 199 | 0 |
30 Jun 21 | 923 | -68 | 199 | 0 |
31 Mar 21 | 918 | -261 | 197 | 0 |
31 Dec 20 | 925 | -328 | 198 | 0 |
30 Sep 20 | 915 | -515 | 196 | 0 |
30 Jun 20 | 895 | -504 | 207 | 0 |
31 Mar 20 | 870 | -334 | 228 | 0 |
31 Dec 19 | 687 | -304 | 208 | 0 |
30 Sep 19 | 803 | -121 | 248 | 0 |
30 Jun 19 | 733 | -107 | 247 | 0 |
31 Mar 19 | 685 | -86 | 241 | 0 |
31 Dec 18 | 627 | -53 | 231 | 0 |
30 Sep 18 | 548 | -49 | 220 | 0 |
30 Jun 18 | 506 | -49 | 206 | 0 |
31 Mar 18 | 468 | -56 | 199 | 0 |
31 Dec 17 | 435 | -61 | 195 | 0 |
30 Sep 17 | 409 | -65 | 191 | 0 |
30 Jun 17 | 362 | -64 | 180 | 0 |
31 Mar 17 | 311 | -55 | 163 | 0 |
31 Dec 16 | 254 | -160 | 148 | 0 |
30 Sep 16 | 212 | -146 | 131 | 0 |
30 Jun 16 | 192 | -147 | 122 | 0 |
31 Mar 16 | 146 | 220 | 103 | 0 |
31 Dec 15 | 97 | 330 | 71 | 0 |
30 Sep 15 | 51 | 322 | 38 | 0 |
30 Jun 15 | 10 | 329 | 13 | 0 |
31 Mar 15 | 0 | -37 | -1 | 0 |
31 Dec 14 | 0 | -31 | 0 | 0 |
30 Sep 14 | 13 | -29 | 7 | 0 |
31 Dec 13 | 26 | 2 | 16 | 0 |
Ingresos de calidad: EVH actualmente no es rentable.
Margen de beneficios creciente: EVH actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: EVH no es rentable, pero ha reducido pérdidas en los últimos 5 años a un ritmo de 35.7% por año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de EVH en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: EVH no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare Services (13.9%).
Rentabilidad financiera
Alta ROE: EVH tiene una rentabilidad financiera negativa (-5.89%), ya que actualmente no es rentable.